NYXH Nyxoah

Publication relating to transparency notifications

Publication relating to transparency notifications

                

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.

On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).

The notification dated November 5, 2024 contains the following information:

  • Reason for the notification: passive crossing of a threshold
  • Notification by: a person that notifies alone
  • Persons subject to the notification requirement:
    • ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
  • Date on which the threshold was crossed: October 9, 2024
  • Threshold that is crossed: 5%
  • Denominator: 37,389,015
  • Notified details:
A) Voting rights Previous notification After the transaction


 
# of voting rights # of voting rights % of voting rights
Holders of voting rights

 
Linked to securities Not linked to the securities Linked to securities Not linked to the securities
ResMed Inc. 1,619,756 1,727,864

 


 


 


 
TOTAL 1,727,864 0 4.62% 0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.



*

* *

Contact:

Nyxoah

John Landry, CFO

Attachment



EN
18/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conf...

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will participate in the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024. The Company is sched...

 PRESS RELEASE

Invitation to attend the special shareholders’ meeting of the Company ...

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 REGULATED INFORMATIONNovember 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 The board of directors of the Company is pleased to invite its securities holders to attend the special shareholders' meeting of the Company, to be held on Thursday, December 19, 2024 at 3:00 p.m. CET at...

 PRESS RELEASE

Invitation à assister à l'assemblée générale spéciale des actionnaires...

Invitation à assister à l'assemblée générale spéciale des actionnaires de la Société qui se tiendra le 19 décembre 2024 INFORMATIONS RÉGLEMENTÉESle 19 novembre 2024, 7:00h CET / 1:00h ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique(ci-après la "Société") Invitation à assister à l'assemblée générale spéciale des actionnaires de la Sociétéqui se tiendra le 19 décembre 2024 Le conseil d'administration de la Société a le plaisir d’inviter ses détenteurs de titres à assister à l'assemblée générale spéciale de la Société, qui se tiendra le je...

 PRESS RELEASE

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Bas...

Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli

ResearchPool Subscriptions

Get the most out of your insights

Get in touch